<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852021000300002</article-id>
<article-id pub-id-type="doi">10.48193/rmu.v81i3.723</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Resultados oncológicos y funcionales de la prostatectomía radical abierta como tratamiento del cáncer de próstata en una cohorte de 1420 pacientes en la Ciudad de México]]></article-title>
<article-title xml:lang="en"><![CDATA[Oncologic and functional results of open radical prostatectomy as treatment of prostate cancer in a cohort of 1420 patients in Mexico City]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres-García]]></surname>
<given-names><![CDATA[Aarón]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarado-Larraguivel]]></surname>
<given-names><![CDATA[Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Téllez]]></surname>
<given-names><![CDATA[Christian Omar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paredes-Hernández]]></surname>
<given-names><![CDATA[Manuel Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruíz-Colín]]></surname>
<given-names><![CDATA[Víctor David]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández de Lara-Escalante]]></surname>
<given-names><![CDATA[Aldo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,The American British Cowdray Medical Center I.A.P ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>81</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852021000300002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852021000300002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852021000300002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La prostatectomía radical abierta, desde principios del siglo pasado ha sido el estándar de oro en el tratamiento del cáncer de próstata localizado, y la plataforma desde la cual procedimientos de invasión mínima como la laparoscopia y la cirugía asistida por robot, han prosperado al reproducir sus resultados.  Objetivo:  Evaluar los resultados oncológicos y funcionales de la prostatectomía abierta en una cohorte de 1420 pacientes en la Ciudad de México.  Material y métodos:  Se diseñó un estudio de cohorte retrospectiva de 1 420 casos de pacientes con cáncer de próstata sometidos a cirugía radical por un solo cirujano (ATG) en varios hospitales de asistencia privada.  Resultados:  La mediana de vigilancia fue de 132 meses (rango de 1 a 180 meses). La sobrevida cáncer específica fue de 95% (95% IC 96 a 98), 90% (95% IC 91 a 93), 87% (95% IC 86 a 89), 83% (95% IC 83 a 86) y 80% (95% IC 79 81), a 5, 10 y 15 años respectivamente. El tiempo libre de progresión bioquímica fue disminuyendo con entre mayor el grupo de riesgo, grado de Gleason y extensión extra prostática al tiempo de la cirugía.  Conclusión:  La prostatectomía radical es un procedimiento que ofrece una sobrevida al cáncer específica, así como sobrevida libre de progresión bioquímica adecuadas para lograr un control de la neoplasia prostática localizada a largo plazo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Open radical prostatectomy, since the beginning of the last century has been the gold standard in the localized prostate cancer treatment, and the platform from which minimally invasive procedures such as laparoscopy and robot-assisted surgery have reproduced its results.  Objective: To evaluate the oncological outcomes and functional results of open radical prostatectomy in a cohort of 1420 patients in Mexico City.  Material and methods: A retrospective cohort study of 1420 cases of patients with prostate cancer undergoing radical surgery for a single surgeon (ATG) in private care hospitals.  Results: The median surveillance was 132 months (range 1 to 180 months). Cancer- specific survival was 95% (95% CI 96 to 9), 90% (95% CI 9 to 9), 7% (95% CI 6 to 9), % (95% CI to 6) and 0% (95% CI 79), at 5, 10 and 15 years respectively. The time free of biochemical progression decreased with greater the risk group, Gleason grade and extraprostatic extension at surgery time.  Conclusion: Radical prostatectomy is up to now a procedure that offers cancer-specific survival as well as survival free of biochemical progression adequate to achieve adequate control of prostate neoplasia.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Open prostatectomy]]></kwd>
<kwd lng="en"><![CDATA[oncological outcomes]]></kwd>
<kwd lng="en"><![CDATA[functional results.]]></kwd>
<kwd lng="es"><![CDATA[Prostatectomía abierta]]></kwd>
<kwd lng="es"><![CDATA[desenlaces oncológicos]]></kwd>
<kwd lng="es"><![CDATA[resultados funcionales]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[erlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[H-R]]></given-names>
</name>
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Forman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mathers]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Parkin]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>2010</year>
<volume>127</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2893-917</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malvezzi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bosetti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chatenoud]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Levi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Negri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in cancer mortality in Mexico, 1970-1999]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2004</year>
<volume>15</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1712-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Dirección General de Información en Salud</collab>
<source><![CDATA[Defunciones (Mortalidad) Cubos dinámicos]]></source>
<year>2020</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-Barriga]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tendencias de mortalidad y años potenciales de vida perdidos por cáncer de próstata en los 32 estados y en las 7 regiones socioeconómicas de México en el periodo 2000-2010]]></article-title>
<source><![CDATA[Gac Med Mex]]></source>
<year>2013</year>
<volume>149</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>576-85</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2002</year>
<volume>168</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>914-21</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Millin]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retropubic prostatectomy; a new extravesical technique; report of 20 cases]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1945</year>
<volume>2</volume>
<numero>6380</numero>
<issue>6380</issue>
<page-range>693-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Lepor]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Eggleston]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations]]></article-title>
<source><![CDATA[Prostate]]></source>
<year>1983</year>
<volume>4</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>473-85</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amling]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Bergstralh]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Blute]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Slezak]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Zincke]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2001</year>
<volume>165</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1146-51</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosen]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Riley]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Osterloh]]></surname>
<given-names><![CDATA[IH]]></given-names>
</name>
<name>
<surname><![CDATA[Kirkpatrick]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mishra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction]]></article-title>
<source><![CDATA[Urology]]></source>
<year>1997</year>
<volume>49</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>822-30</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clavien]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Barkun]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[de Oliveira]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Vauthey]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Dindo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schulick]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Clavien-Dindo classification of surgical complications: five-year experience]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>2009</year>
<volume>250</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>187-96</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mullins]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Trock]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Loeb]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2012</year>
<volume>188</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2219-24</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stephenson]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kattan]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Eastham]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Bianco]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Yossepowitch]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Vickers]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2009</year>
<volume>27</volume>
<numero>26</numero>
<issue>26</issue>
<page-range>4300-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zincke]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Oesterling]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Blute]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Bergstralh]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Barrett]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1994</year>
<volume>152</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1850-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[WK]]></given-names>
</name>
<name>
<surname><![CDATA[Blute]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Bostwick]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Weaver]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Sebo]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zincke]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2001</year>
<volume>166</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1692-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kotb]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Elabbady]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors for the development of biochemical recurrence after radical prostatectomy]]></article-title>
<source><![CDATA[Prostate Cancer]]></source>
<year>2011</year>
<volume>2011</volume>
<page-range>485189</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boorjian]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Karnes]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rangel]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bergstralh]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Blute]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mayo Clinic validation of the D&#8217;amico risk group classification for predicting survival following radical prostatectomy]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2008</year>
<volume>179</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1354-60</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dorin]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Daneshmand]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lassoff]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Cai]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Skinner]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Lieskovsky]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era]]></article-title>
<source><![CDATA[Urology]]></source>
<year>2012</year>
<volume>79</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>626-31</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suardi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Porter]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Reuther]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Walz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kodama]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbons]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A nomogram predicting long-term biochemical recurrence after radical prostatectomy]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2008</year>
<volume>112</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1254-63</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hull]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Rabbani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Abbas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Wheeler]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Kattan]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Scardino]]></surname>
<given-names><![CDATA[PT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer control with radical prostatectomy alone in 1,000 consecutive patients]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2002</year>
<volume>167</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>528-34</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roehl]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Antenor]]></surname>
<given-names><![CDATA[JAV]]></given-names>
</name>
<name>
<surname><![CDATA[Catalona]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2004</year>
<volume>172</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>910-4</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Partin]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Pound]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience]]></article-title>
<source><![CDATA[Urol Clin North Am]]></source>
<year>2001</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>555-65</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eggener]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Scardino]]></surname>
<given-names><![CDATA[PT]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Partin]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Trock]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting 15-year prostate cancer specific mortality after radical prostatectomy]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2011</year>
<volume>185</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>869-75</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
